Viewing nowCombinationCandeamlo Tablets 8/5 mg
Candesartan Cilexetil 8mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 201603934 · Approved 2016.06.24 · Insurance code 648507590
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with either Candesartan Cilexetil or Amlodipine monotherapy, to effectively lower blood pressure.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose of each individual component (candesartan cilexetil or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. -8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or this medicine 16/5 mg. Patients taking candesartan cilexetil and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. • Patients with renal impairment: Since an initial dose of candesartan cilexetil of 4 mg once daily is recommended for patients with renal impairment, it is not advisable to use this medicine as initial treatment. • Patients with hepatic impairment: Since an initial dose of candesartan cilexetil of 2 mg once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this medicine as initial treatment.
Adolescents and children aged 18 years or younger: Use of this medicine is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn during pregnancy, so treatment must be stopped immediately if pregnancy is confirmed. Patients with hypersensitivity to this medicine, pregnant or breastfeeding women, patients with severe liver disease or cholestasis, patients with severe renal impairment, and patients with hereditary angioedema should not take this medication. Elderly patients, patients with hyperkalemia, patients with slightly impaired liver function, patients with hypotension, patients with heart valve disease, and patients with reduced kidney function should use this medication with caution. This medication lowers blood pressure, which can result in side effects such as dizziness, headaches, fatigue, chest discomfort, peripheral edema, muscle pain, and gastrointestinal symptoms. Regular monitoring of kidney function and electrolyte status is essential, and care should be taken to avoid excessively low blood pressure. This medication may interact when taken with other antihypertensives, diuretics, potassium supplements, etc., so it should be taken only after consulting with a healthcare professional. Caution is required when driving or operating machinery due to possible dizziness. If pregnant or breastfeeding, the use of this medication should be avoided, and if absolutely necessary, a decision should be made after consulting a specialist. Use is not recommended for children or adolescents under 18 years old, as safety and efficacy have not been established. In case of overdose, symptoms such as decreased blood pressure, dizziness, and tachycardia may occur, and immediate medical attention is required. This medication should be stored out of reach of children and not transferred to another container; care should be taken to maintain quality during storage.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.
Pink, double convex, round, film-coated tablet
300 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationCandesartan Cilexetil 8mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationCandesartan Cilexetil 16mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.